GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Eat Rich, Live Long: Mastering the Low-Carb & Keto Spectrum for Weight Loss and Longevity
amazon.com
As devastating as it is, cirrhosis is not the only end point I’m worried about here. I care about NAFLD and NASH—and you should too—because they represent the tip of the iceberg of a global epidemic of metabolic disorders, ranging from insulin resistance to type 2 diabetes. Type 2 diabetes is technically a distinct disease, defined very clearly by
... See morePeter Attia MD • Outlive: The Science and Art of Longevity
A 2020 study found that obesity is linked to a sixfold increased risk of developing type 2 diabetes.
Marc Milstein • The Age-Proof Brain
Direct-to-consumer products that make explicit claims about wellness and lifestyle but imply health benefits for serious medical conditions are particularly concerning. These products easily bypass the current regulatory radar. For example, a fitness product might imply health benefits for patients with cardiovascular disease despite never being te... See more
E Ray Dorsey • Just a moment...
Risk factors for contralateral inguinal hernia repair after unilateral inguinal hernia repair in male adult patients: analysis from a nationwide population based cohort study - BMC Surgery
Cheng-Hung Leebmcsurg.biomedcentral.com
GLP-1s are master signals that governs the body's state of being either well-fed or starving. This signal influences numerous bodily processes, including metabolism, inflammation, and reward systems. This broad influence on these fundamental processes may explain why GLP-1s appear to be effective across so many conditions.